Verification of [4(1,2-Di Hydro -4,6-Dihydroxy Pyrimidine -2- Yh Thio)-3-Hydroxy-5-(2,2-Dimethyl-1,3-Dioxolan-4-Yl) Furan-2(5H)One] Properties as Antioxidants in Experimental Animals Induced with Diabetes.
Abstract
Diabetes mellitus (DM) associated with Oxidative stress which indicates the imbalance between reactive oxygen species (ROS) and defensive antioxidants system. In this work it has been proved that compound [4(1,2-di hydro -4,6-dihydroxy pyrimidine -2- yH thio)-3-hydroxy-5-(2,2-dimethyl-1,3-dioxolan-4-yl) furan-2(5H)one](3A) works as antioxidant compared with other used in this study. Rabbits used were divided into the induced diabetic rabbits (n=5) , rabbits control (n=5), treatment groups with following antioxidants aspirin (n=5) ,GSH(n=5) ,Vitamin C (n=5) and with preparation compound (3A) (n=5) which believed to be as antioxidants, The results show that levels of serum glucose and MDA in diabetic rabbits were significantly increased (p<0.000) for both as compared with control group and significantly decreased in treatment groups with aspirin, GSH, Vit C, and (3 A) while the level of membrane protein has been significantly decreased (p<0.000) as compared with control group and significantly decreased in treatment groups with aspirin, GSH, Vit C, and (3 A), these results verified that compound ( 3A) considered as antioxidant, but another study needs to detect the ability to used as drug.
Keyword: Diabetes Mellitus, Malondialdehyde(MDA), Aspirin, Reduced glutathione ( GSH), 3A.
To list your conference here. Please contact the administrator of this platform.
Paper submission email: CPER@iiste.org
ISSN (Paper)2224-7467 ISSN (Online)2225-0913
Please add our address "contact@iiste.org" into your email contact list.
This journal follows ISO 9001 management standard and licensed under a Creative Commons Attribution 3.0 License.
Copyright © www.iiste.org